The exact protection mechanism of the universal vaccine against influenza A virus matrix protein 2 ectodomain (M2e) is not yet clear, but it can reduce influenza symptoms and inhibit virus replication, survival and transmission. Moreover, the actual protection effect can be improved by using M2e tetrameric universal vaccine, M2e virus-like particle vaccine and M2e multi-epitope universal vaccine combined with adjuvant, which have great value for future application. This paper reviews the research status, immune mechanism, and characteristics of influenza A virus M2e universal vaccines by collecting relevant literature as well as combining with clinical practice and relevant animal experiments, in order to provide a theoretical basis for related research.